FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099730871> ?p ?o ?g. }

• W2099730871 endingPage "1453.e9" @default.
• W2099730871 startingPage "1443" @default.
• W2099730871 abstract "The relative effectiveness and tolerability of treatments for type 2 diabetes mellitus (T2DM) is not well understood because few randomized, controlled trials (RCTs) have compared these treatments directly. The purpose of the present study was to evaluate the relative effectiveness and tolerability of treatments of T2DM.We performed a network meta-analysis of available RCTs with pharmacologic interventions in T2DM and compared antidiabetic drugs and combination regimens with metformin (the reference drug). Glycemic control (proportion achieving HbA1c goal) and tolerability (risk of hypoglycemia) were the primary outcomes of interest. Direct and indirect relative effects (unadjusted) were expressed as odds ratios and 95% CIs.Eight treatments (glucagon-like peptide-1 [GLP-1] agonists plus metformin, sulfonylureas plus metformin, dipeptidyl peptidase-4 [DPP-4] inhibitors] plus metformin, colesevelan plus metformin, thiazolidinediones plus metformin, meglitinides plus metformin, α-glucosidase inhibitor plus metformin, and rosiglitazone monotherapy) outperformed metformin (direct effects). Triple combinations of GLP-1, thiazolinedione, insulin, metiglinide, or sulfonylureas added to a metformin backbone improved glycemic control (indirect effects). Higher risk of hypoglycemia was noted for sulfonylureas, α-glycosidases, and metiglinides when added to metformin (direct effects). Across indirect effects, only 17% of comparisons yielded less risk of hypoglycemia (70% were worse and 13% were comparable).Our results point out the relative superiority of 2- and 3-drug combination regimens over metformin and summarize treatment effects and tolerability in a comprehensive manner, which adds to our knowledge regarding T2DM treatment options." @default.
• W2099730871 created "2016-06-24" @default.
• W2099730871 creator A5000950219 @default.
• W2099730871 creator A5001186115 @default.
• W2099730871 creator A5006346169 @default.
• W2099730871 creator A5006559598 @default.
• W2099730871 creator A5008105437 @default.
• W2099730871 creator A5008309468 @default.
• W2099730871 creator A5016234007 @default.
• W2099730871 creator A5025314263 @default.
• W2099730871 creator A5054344299 @default.
• W2099730871 creator A5056914151 @default.
• W2099730871 creator A5062282892 @default.
• W2099730871 creator A5070060496 @default.
• W2099730871 creator A5071075117 @default.
• W2099730871 creator A5071396125 @default.
• W2099730871 creator A5080401925 @default.
• W2099730871 creator A5086966278 @default.
• W2099730871 date "2014-10-01" @default.
• W2099730871 modified "2023-10-16" @default.
• W2099730871 title "Assessment of the Relative Effectiveness and Tolerability of Treatments of Type 2 Diabetes Mellitus: A Network Meta-analysis" @default.
• W2099730871 cites W1678147663 @default.
• W2099730871 cites W1971895240 @default.
• W2099730871 cites W1975588287 @default.
• W2099730871 cites W2005947177 @default.
• W2099730871 cites W2009944328 @default.
• W2099730871 cites W2016880798 @default.
• W2099730871 cites W2029388248 @default.
• W2099730871 cites W2033768383 @default.
• W2099730871 cites W2049032499 @default.
• W2099730871 cites W2060143655 @default.
• W2099730871 cites W2072921961 @default.
• W2099730871 cites W2090244618 @default.
• W2099730871 cites W2099326967 @default.
• W2099730871 cites W2104983431 @default.
• W2099730871 cites W2107328434 @default.
• W2099730871 cites W2109771427 @default.
• W2099730871 cites W2130189158 @default.
• W2099730871 cites W2133531206 @default.
• W2099730871 cites W2137746085 @default.
• W2099730871 cites W2140699272 @default.
• W2099730871 cites W2149012794 @default.
• W2099730871 cites W2150802886 @default.
• W2099730871 cites W2172193326 @default.
• W2099730871 cites W2188846692 @default.
• W2099730871 cites W2786617581 @default.
• W2099730871 doi "https://doi.org/10.1016/j.clinthera.2014.06.035" @default.
• W2099730871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25109773" @default.
• W2099730871 hasPublicationYear "2014" @default.
• W2099730871 type Work @default.
• W2099730871 sameAs 2099730871 @default.
• W2099730871 citedByCount "17" @default.
• W2099730871 countsByYear W20997308712015 @default.
• W2099730871 countsByYear W20997308712016 @default.
• W2099730871 countsByYear W20997308712017 @default.
• W2099730871 countsByYear W20997308712018 @default.
• W2099730871 countsByYear W20997308712019 @default.
• W2099730871 countsByYear W20997308712020 @default.
• W2099730871 countsByYear W20997308712022 @default.
• W2099730871 crossrefType "journal-article" @default.
• W2099730871 hasAuthorship W2099730871A5000950219 @default.
• W2099730871 hasAuthorship W2099730871A5001186115 @default.
• W2099730871 hasAuthorship W2099730871A5006346169 @default.
• W2099730871 hasAuthorship W2099730871A5006559598 @default.
• W2099730871 hasAuthorship W2099730871A5008105437 @default.
• W2099730871 hasAuthorship W2099730871A5008309468 @default.
• W2099730871 hasAuthorship W2099730871A5016234007 @default.
• W2099730871 hasAuthorship W2099730871A5025314263 @default.
• W2099730871 hasAuthorship W2099730871A5054344299 @default.
• W2099730871 hasAuthorship W2099730871A5056914151 @default.
• W2099730871 hasAuthorship W2099730871A5062282892 @default.
• W2099730871 hasAuthorship W2099730871A5070060496 @default.
• W2099730871 hasAuthorship W2099730871A5071075117 @default.
• W2099730871 hasAuthorship W2099730871A5071396125 @default.
• W2099730871 hasAuthorship W2099730871A5080401925 @default.
• W2099730871 hasAuthorship W2099730871A5086966278 @default.
• W2099730871 hasConcept C126322002 @default.
• W2099730871 hasConcept C134018914 @default.
• W2099730871 hasConcept C197934379 @default.
• W2099730871 hasConcept C2777180221 @default.
• W2099730871 hasConcept C2778375690 @default.
• W2099730871 hasConcept C2778763485 @default.
• W2099730871 hasConcept C2779306644 @default.
• W2099730871 hasConcept C2780323712 @default.
• W2099730871 hasConcept C2780473172 @default.
• W2099730871 hasConcept C2780668416 @default.
• W2099730871 hasConcept C2910068830 @default.
• W2099730871 hasConcept C555293320 @default.
• W2099730871 hasConcept C71924100 @default.
• W2099730871 hasConcept C98274493 @default.
• W2099730871 hasConceptScore W2099730871C126322002 @default.
• W2099730871 hasConceptScore W2099730871C134018914 @default.
• W2099730871 hasConceptScore W2099730871C197934379 @default.
• W2099730871 hasConceptScore W2099730871C2777180221 @default.
• W2099730871 hasConceptScore W2099730871C2778375690 @default.
• W2099730871 hasConceptScore W2099730871C2778763485 @default.
• W2099730871 hasConceptScore W2099730871C2779306644 @default.
• W2099730871 hasConceptScore W2099730871C2780323712 @default.

• next